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Abstract
Despite comparable levels of virus replication, simian immunodeficiency viruses (SIV) infection is non-pathogenic in natural
hosts, such as sooty mangabeys (SM), whereas it is pathogenic in non-natural hosts, such as rhesus macaques (RM).
Comparative studies of pathogenic and non-pathogenic SIV infection can thus shed light on the role of specific factors in
SIV pathogenesis. Here, we determine the impact of target-cell limitation, CD8+ T cells, and Natural Killer (NK) cells on virus
replication in the early SIV infection. To this end, we fit previously published data of experimental SIV infections in SMs and
RMs with mathematical models incorporating these factors and assess to what extent the inclusion of individual factors
determines the quality of the fits. We find that for both rhesus macaques and sooty mangabeys, target-cell limitation alone
cannot explain the control of early virus replication, whereas including CD8+ T cells into the models significantly improves
the fits. By contrast, including NK cells does only significantly improve the fits in SMs. These findings have important
implications for our understanding of SIV pathogenesis as they suggest that the level of early CD8+ T cell responses is not
the key difference between pathogenic and non-pathogenic SIV infection.
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Introduction
The simian immunodeficiency virus (SIV) occurs as a natural
infection in several Old-world monkey species, such as sooty
mangabeys (SM) or African green monkeys [1,2]. In striking
contrast to HIV infection of humans, SIV infection does not cause
disease in natural hosts. The levels of virus replication, however,
are similarly high in natural hosts and non-natural hosts such as
rhesus macaques (RM), in which SIV causes AIDS-like symptoms.
Comparative studies of SIV infection in natural and non-natural
hosts provide the opportunity to investigate the interaction
between the virus and the host immune system in pathogenic
and non-pathogenic infection. Such a comparison might shed light
on the mechanisms of disease progression in pathogenic SIV and
by extrapolation on HIV.
Although natural and non-natural hosts allow similar levels of
virus replication, there are interesting immunological differences:
SMs do not exhibit the increased CD4+ T cell turnover and the
generalized immune activation that is characteristic for the SIV
infection of RMs or HIV-infection in humans [3,4]. Thus, virus
load alone cannot be the key to understanding pathogenesis.
Silvestri and Feinberg [5] interpreted these findings in favor of the
hypothesis that HIV disease progression is a result of generalized
immune activation rather than of the destruction of CD4+ T cells
by the virus alone. This view of HIV pathogenesis is a derivative of
the immuno-pathological hypothesis [6]. Because primary HIV
infection is a period critical for the future immune responses’
capability of controlling the infection [7,8], the potential
differences between pathogenic and non-pathogenic SIV infection
are likely to manifest themselves early in infection.
In both RMs and SMs, the early SIV infection is divided into
three phases. The first phase is characterized by a sharp increase of
virus load soon after infection. The second phase describes the
decline of virus load that follows the initial peak viremia. The third
phase finally describes the largely stable equilibrium virus load that
eventually establishes after the decline. This stable virus load is also
referred to as the viral set point. The characteristic pattern of virus
load in primary SIV infection can be explained either through the
delayed action of cellular immunity [9,10] or through target cell
limitation [11] or both. Note that in this context the term target-
cell limitation refers to the hypothesis that the level of target cells
on its own can explain the early virus-load dynamics [11]. Regoes
et al. [9] investigated these hypotheses by fitting mathematical
models to viral loads of SIVmac239-infected RMs that exhibited
either normal or experimentally impaired cellular immunity as a
result of co-stimulatory blockade. This analysis showed that target-
cell limitation can explain the virus-load dynamics in the animals
with impaired cellular immunity but not in those with a normal
immune response. In the latter case, the models could explain the
virus-loads only if cellular immunity is also taken into account.
These results imply that target-cell limitation alone cannot explain
the level of virus replication during primary SIVmac239 infection
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determining the post-peak decline of viremia.
In this article, we use the method of Regoes et al. [9] to
analyze the early virus dynamics in non-pathogenic SIV
infection of sooty mangabeys (SM). In particular, we sought to
determine the roles that target-cell limitation, CD8+ T cell
responses and NK cells play in primary infection of SMs, and to
compare the impact of these factors with that in SIV-infected
RMs. To this end we fit the measurements of virus load with
population-dynamic models that differ as to whether they take
factors such as cellular immunity or NK cells into account.
Comparing the goodness of fit of these models, we can then
evaluate the role of these factors in the primary infection of
pathogenic and non-pathogenic SIV.
Results
We used previously published data of experimental SIV
infections (see Figure 1) to assess the relative importance of
target-cell limitation, CD8+ T cells, and NK cells for controlling
virus replication in primary SIV infection. To this end, we
determined to what extent the ability of mathematical models to fit
the early virus dynamics depends on the inclusion of these factors
(see Figure 2). We start by showing that CD8+ T cells in
combination with target-cells, but not target cells on their own, can
explain the early SIV dynamics in RMs. Then we show that
cellular immunity has a similar effect in early SIV replication of
both RMs and SMs. Finally, we argue that NK cells only have an
impact on the early replication in SMs.
The target-cell model aims to explain the virus-load dynamics
through target-cell limitation only (equation 1), whereas the CD8+
T cell model takes both target-cell limitation and cellular
immunity into account (equation 2). We use the density of
proliferating CD4+ T-cells and of proliferating CD8+ T-cells as
proxies for the size of the target cell population and for the
strength of the specific cellular immunity. Comparing these two
models assesses the relative role of target-cell limitation and
cellular immunity in controlling the virus load: A good fit of the
target-cell model and an only insignificant improvement in the
CD8+ T cell model, would suggest that the virus load is mainly
controlled by target-cell limitation. On the contrary, a bad fit of
the target-cell model and a significant improvement in the CD8+
T cell model, would support the view that cellular immunity plays
an important role.
Target-cell limitation does not explain virus control in
rhesus macaques
The analysis of the RM data reconfirms the results of Regoes
et al. [9] in an extended dataset. In particular, we find that target-
cell limitation alone cannot explain the virus dynamics. For all
animals except one (animal RPB8), the best fit of the target-cell
model predicts a steadily increasing virus load (black lines in
Figure 3), i.e. the fit fails to explain the characteristic peak and the
Figure 1. Measurements of virus loads and cell counts.
Measurements of virus load (first row), proliferating CD4+ T-cells
(second row), proliferating CD8+ T-cells (third row), and NK cells (fourth
row) in sooty mangabeys and rhesus macaques.
doi:10.1371/journal.pcbi.1000901.g001
Figure 2. Illustration of the model comparisons. Comparisons i)
and iii) test whether taking CD8+ T cells into account improves the fits
of the target-cell model and the NK model, respectively. Comparisons ii)
and iv) test whether taking NK cells into account improves the fits of
the target-cell model and the CD8+ T cell model respectively.
doi:10.1371/journal.pcbi.1000901.g002
Author Summary
Simian immunodeficiency viruses (SIV) are typically non-
pathogenic in their natural hosts. However, if the same
virus infects a non-natural host it often leads to AIDS-like
symptoms. Therefore, comparing SIV infections in these
two types of host might help explain the pathogenesis of
SIV in non-natural hosts and thereby also that of HIV. We
combined mathematical modeling with data on the levels
of virus and immune cells early in infection, and compared
both non-pathogenic SIV infections of sooty mangabeys
and pathogenic SIV infection of rhesus macaques with
respect to how the virus grows in them and to what extent
it is controlled by the immune system. We found that the
impact of the immune system on early virus replication is
remarkably similar in both species. In particular, for both
species virus replication can only be explained by the
effect of CD8+ T cells. These findings have important
implications for our understanding of SIV pathogenesis as
they suggest that the impact of the early immune
responses is not the key difference between pathogenic
and non-pathogenic SIV infection.
Impact of CD8+ T Cell Responses in SIV in RM/SM
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quality of the fit is poor even for the animal for which the target-
cell model can predict a viral load decrease. Adding specific
cellular immunity to the target-cell model does significantly
improve the fit for RMs (F-test, p=2.8610
218). Importantly, the
CD8+ T cell model can explain the characteristic post-peak
decline of the viral load (green lines in Figure 3).
Target-cell limitation does not explain virus control in
sooty mangabeys
The results of our analysis of the data from SIV infection of SMs
are strikingly similar to those obtained for the rhesus macaques:
The target-cell model fails to explain the virus dynamics for all
eight animals (Figure 3), whereas the CD8+ T cell model provides
a significantly better fit (F-test, p=1.3610
211), which can
reproduce the qualitative patterns of the virus dynamics. The
only exception is the animal FSS, for which both the target-cell and
the CD8+ T cell model produce poor fits. The poor quality of
these fits might be due to the fact that this animal exhibits a
comparatively early increase of target-cell number and a
comparatively late increase of CD8+ T-cell number (see
Figure 1). The similarity of the results in SMs and RMs suggests
that the relative importance of specific cellular immunity and
target-cell limitation during early infection is comparable in
pathogenic and non-pathogenic SIV hosts. In both cases, the
temporal dependence of the viral load can only be explained if
CD8+ T cells are taken into account.
Table 1 shows the best-fit estimates and the confidence intervals
for the parameters of the CD8+ T cell model. The parameters r
and k quantify the per-cell impact of target-cells and CD8+ T-cells
on the viral replication rate (see equation 2). Both parameters are
on average higher for sooty mangabeys: r roughly by a factor 6 and
k by a factor 3. Furthermore, the intrinsic death rates of infected
cells, a, were estimated to be 0 for most animals. This suggests that,
for both SMs and RMs, most deaths of infected cells are caused by
cellular immunity (see [9]).
Figure3. Bestfits ofvirus load data. Best fits by the target-cell model
(black lines) and the CD8+ T cell model (green lines) of the virus load
measurements (red dots) of sooty mangabeys and rhesus macaques.
doi:10.1371/journal.pcbi.1000901.g003
Table 1. Parameter estimates.
Animal a(95% CI) r (95% CI) k (95% CI) SSQ1 SSQ2
Sooty Mangabeys
FFS 0 (0,8) 0.1 (0.077,0.92) 0.017 (0.012,0.09) 3.3 29
FRS 0 (0,2.8) 0.08 (0.0011,0.6) 0.033 (0.0021,0.19) 25 30
FSS 0 (0,8.8) 0.055 (0.046,0.67) 0.011 (0.0092,0.099) 4.2 27
FUV 0 (0,3.6) 0.21 (0.19,0.62) 0.066 (0.056,0.12) 2.3 23
FWV 1.8 (0,150) 0.19 (0.094,7.9) 0.011 (0.0023,0.19) 1.6 30
FWo 0.2 (0,2.2) 0.45 (0.35,0.78) 0.11 (0.094,0.13) 0.21 33
FWn 0.71 (0.26,2.2) 0.19 (0.14,0.3) 0.055 (0.041,0.063) 0.15 25
FYl 1.1 (0,1.9) 0.16 (0.084,0.25) 0.03 (0.021,0.047) 0.69 30
Rhesus Macaques
RPB8 2.6 (0,5.3) 0.059 (0.019,0.1) 0.017 (0.0088,0.024) 1.9 12
RSO8 4.2 (0,24) 0.055 (0.0021,0.28) 0.0085 (0.0035,0.017) 0.3 6.3
RYE8 0 (0,13) 0.016 (0.015,0.23) 0.015 (0.014,0.12) 0.41 12
RZS8 0 (0,0) 0.025 (0.021,0.038) 0.009 (0.007,0.02) 1.6 22
rbm 0.017 (0,2) 0.034 (0.031,0.082) 0.037 (0.034,0.07) 0.67 25
roz 0 (0,0.28) 0.018 (0.017,0.023) 0.0043 (0.0032,0.0047) 0.13 11
rvy 0 (0,29) 0.028 (0.023,0.53) 0.011 (0.0089,0.029) 3.8 30
ryt 0 (0,0.22) 0.043 (0.035,0.056) 0.011 (0.008,0.015) 2.2 34
Parameter estimates for the best fit with the CD8+ T cell model (a, r,a n dk). Residual sum of squares of the CD8+ T cell model (SSQ1) and the target-cell model (SSQ2).
The confidence intervals (CI) are derived from bootstrap estimates for 1000 re-sampled datasets. The re-sampling involved choosing time-points with replacement.
Rates are given in units of days
21.
doi:10.1371/journal.pcbi.1000901.t001
Impact of CD8+ T Cell Responses in SIV in RM/SM
PLoS Computational Biology | www.ploscompbiol.org 3 August 2010 | Volume 6 | Issue 8 | e1000901Impact of NK-cells in rhesus macaques and sooty
mangabeys
The NK cell model and the CD8+ T cell & NK model are
obtained from the target-cell and the CD8+ T cell model by
adding NK cell number as an explanatory variable. We consider
the fits of these extended models for two reasons: First, to test
whether the above results are robust against adding NK cells to the
model and, second, to investigate the role of an important effector
mechanism of the innate immune system during primary SIV
infection. In total, four types of statistical comparisons were
performed (see Figure 2): Comparison i) between the target-cell
model and the CD8+ T cell model is the one discussed above.
Comparison ii) between the target-cell model and the NK model
evaluates whether adding NK cells to target-cell limitation
improves significantly the quality of fit. Comparison iii) between
the NK model and the CD8+ T cell-NK model evaluates whether
taking cellular immunity into account improves the fit of the NK
model. Finally, comparison iv) assesses whether NK-cell number
does significantly improve the fit of the CD8+ T cell model.
NK cell counts were available for 8 SMs (FWo, FYl, FWn, FFS,
FRS, FSS, FUV, FWV) and 4 RMs (RPB8, RSO8, RYE8, RZS8). If
the number of all NK cells is used as a proxy of NK cell activity,
extending the target cell based model by NK cells (comparison ii)
does improve the model fits significantly only for SM but not for
RM (F-test, p=0.016 and p=0.24 for SM and RM, respectively).
Extending the CD8+ T cell model by NK cells failed for both
species to improve the model fits significantly (F-test, p=0.98 and
p=0.33 for SM and RM, respectively). In contrast, extending the
NK model by CD8+ T cells improves the fit significantly (F-test,
p=2.4610
25 and p=5.7610
24 for RM and SM, respectively). If
the number of proliferating NK cells is used as a proxy of NK cell
activity, including NK cells again significantly improves the target-
cell based model only for SM (F-test, p=1.3610
25 and p=0.33
for SM and RM, respectively). In addition, including NK cell
activity via this proxy also improves the CD8+ T cell model for
SM (F-test, p=0.00013 and p=0.97 for SM and RM, respective-
ly). These results suggest that NK cells play a role in the early
infection of SM but not of RM.
Discussion
The role of cellular immunity in early SIV/HIV infection has
been a debated topic since the suggestion of Phillips [11] that early
virus replication might be controlled by target-cell limitation.
Several lines of evidence suggest however that cellular immunity is
an important force for the control of early SIV replication. First,
the post-peak decline of virus load coincides temporally with the
rise of CTLs [12](although this is also consistent with the
alternative explanation of [11]). Second, [10] have shown that
the post-peak decline of virus-load is significantly weakened if
CD8+ T-cells are depleted. Third, the ubiquitous selection for
mutants that escape CTL response [13] also suggests an important
role of cellular immunity. Fourth, it has been shown that the
patients’ ability to control HIV depends strongly on the alleles at
the HLA and KIR loci [14], which control the action of CD8 T
cells and NK cells, respectively. More recently, some of the
authors of this paper [9] have shown that mathematical models
can explain the early virus dynamics if they take both target-cells
and CD8+ T-cells into account, but not if they take only target
cells into account. Our study extends this previous work by
considering the impact of NK cells, important effectors of innate
immunity. In addition to the extended analysis of the early viral
dynamics in pathogenic SIV infection, we here compare our
results to non-pathogenic SIV infection in sooty mangabeys (SMs).
This comparison has important implications for our understanding
of pathogenesis.
Our analysis confirms the earlier finding of [9] that target-cell
limitation alone cannot explain the virus dynamics in RMs. We
find that, in SIV-infected sooty mangabeys, target-cell limitation is
equally unable to explain the viral load dynamics during early
infection. In both species, our model can only explain the virus
dynamics if it takes cellular immunity into account. This suggests
that specific cellular immunity plays an important role in
determining the dynamics of virus replication during early
infection in both species. We, however, also found that a model,
which assumes a constant viral replication rate, independent of
target cells, was unable to fit the virus-load data of all animals
consistently (results not shown). This implies that, although target
cells alone cannot explain the virus-load dynamics, in particular
the peak and the post-peak decline, temporal variation of target
cells is nevertheless important. Overall, our results indicate that
the relative impact of target-cell limitation and specific cellular
immunity is similar in RMs and SMs.
These results give rise to testable predictions. If, for example,
one would selectively deplete NK cells during primary infection,
the pattern of virus load should be affected in SM, but not in RMs.
In contrast, selective depletion of CD8+ T cells is predicted to lead
to a loss of control of virus replication in both species. Of note, all
depletion experiments performed using an anti-CD8 antibody
depleted CD8+ T cells as well as NK cells because both cell types
express CD8 [10]. In RMs, treatment with a costimulatory
inhibitor, which prevented the development of SIV-specific
cellular and humoral immunity and reduced target cell levels,
gave rise to target cell limited virus replication [9]. The similarity
between the factors governing virus replication predicts that an
analogous treatment of SMs would also lead to target cell
limitation.
Our conclusions about the role of cellular immunity and target-
cell limitations are based on several assumptions. First, the virus
loads and the immune-cell densities were measured in the blood,
which is not the main compartment of SIV replication and
lymphocytes. Our analysis, therefore, relies on the assumption that
the measurements in the blood reflect the situation in the whole
body. In this context, it has been suggested that target-cell
depletion in the gut might play an important role in the early SIV
infection [15,16,17,18,19,20,21,22]. However, a recent study has
shown that in SIV infections of both SM and RM, the target-cell
depletion in the gut occurs too early to explain the peak in virus-
load [23]. Second, our models consider only the primary phase of
SIV infection. Therefore, our conclusion that cellular immunity
does not differ in pathogenic and non-pathogenic SIV, does only
apply to this phase. It might thus be that cellular immunity at later
phases plays a very different role in RMs and SMs, as suggested by
numerous comparative studies [2,3,24,25]. As discussed in Regoes
et al. [9], it is difficult to extend the approach used here to later
phases of infection, because immune-escape and antibody
responses would require considerably more complicated models.
Last, we cannot exclude that different cell compartments or cell
types play the role of target cells in the SIV infections of sooty
mangabeys and rhesus macaques. Indeed, our model fits result in
larger replication rate constants, r, for SM than for RM, which
either suggests a better target cell utilization in SM, or is an
indication that Ki67+ CD4+ T cells do not play the same roles in
SM and RM. Such an effect could systematically bias our analysis
if our proxy (i.e. proliferating CD4+ cells) would be representative
for target cells in one species but not in the other. Finally, the p
values of the model comparisons rely on the assumptions of
normality and independence, which might be violated in our data.
Impact of CD8+ T Cell Responses in SIV in RM/SM
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might potentially lead to an overestimate of the degrees of freedom
and thereby to an underestimate of those p-values. However, it
should be noted that independently of the statistical evaluation, the
least-squares approach is a simple and intuitive method to fit
dynamical models to data, and these fits clearly (Figure 3) show
that for all animals except one RM (RPB8), the best fit of the
target-cell-limitation model fails to predict a post-peak decrease in
virus-load. This suggests that our results regarding the CTLs are
robust against these (in principle valid) statistical concerns. By
contrast, adding NK cells to the model leads to smaller
improvements of the fits and therefore these findings may be
more vulnerable to potential autocorrelations.
One important caveat mentioned in the previous section is the
uncertainty as to whether the measured cell populations (e.g.
Ki67+ CD4+ T-Cells, Ki67+ CD8+ T-Cells, NK cells) can be
identified with populations performing a specific function (target
cells, cytotoxic T cells, cytotoxic NK cells). This potential problem
is substantially alleviated by the way these measurements are
integrated into our model. Specifically, the quality of fit as
measured by the residual sum of squares, is invariant with respect
to a linear transformation of the variables. I.e. if we measure the
cell population x but the active population is x9=a x-b we will
obtain the same quality of fit regardless of whether we incorporate
xo rx 9 into our model. Therefore it does not matter whether only
a fraction of the measured cells is active or whether a constant
number of the measured cells is inactive. For practical reasons,
however, it is important that the fraction of the active cells is not
too small relative to the inactive cells, because then the noise in the
latter is likely to overwhelm the signal in the former. This
reasoning implies that the comparison of the quality of fit of the
different models (Figure 2) is much more robust than the
parameter estimates (Table 1): In principle, the first type of
analysis (model comparison) still works, even if the linear
transformation (relating measured cell populations to the cell-
populations performing a specific function) is different for each
animal. By contrast, the second type of analysis (parameter
estimation) requires that this transformation is similar in the
animals compared. For these reasons, we conclude that not too
much weight should be given to the parameter estimates, as they
rely much stronger on a good match between measured cell
populations and the populations actually performing a certain
function, while we can assert that the model comparison is robust.
The fundamental robustness of the method also explains why [9]
found qualitatively similar results with Ki67+ CD8+ T-cells and
tetramer positive T-cells as markers for SIV-specific cellular
immunity.
As SIV infection is pathogenic in rhesus macaques but non-
pathogenic in sooty mangabeys, our results can be interpreted in
the context of current theories of SIV pathogenesis, in particular
with respect to reasons underlying the absence of disease
progression in SIV-infected SMs. While an initial study suggested
that acute SIV infection of SMs is characterized by limited to
absent T cell activation [25], a number of more recent studies that
included a more comprehensive sample collection have shown
very clearly that SMs exhibit substantial T cell activation during
acute SIV infection [24,26,27,28]. However, in marked contrast
with SIV-infected RMs, sooty mangabeys are able to rapidly and
dramatically reduce the level of T cell activation during the early
chronic infection (i.e., starting at day 30 post inoculation)
[24,26,27,28]. Although our model comparison did not directly
test differences in the antigenicity of SIV between SM and RM,
our results are more consistent with the latter observations and
suggest that the divergent outcome of SIV infection in RMs and
SMs is not caused by differences in CD8+ T-cell response during
the early stages of infection.
Methods
Ethics statement
All the experiments on non-human primates from which these
data are sampled have been approved by the Institutional Animal
Care and Use Committee (IACUC). All these experiments have
been described in previous publications.
Data
The data analyzed in this article were generated in experimental
infections of SMs infected with the viral strain SIVsmm and of
rhesus macaques infected with the strains SIVmac (animals rbm, rvy,
roz, ryt) or SIVsmm (animals RPB8, RSO8, RYE8, RZS8, RFT8). A
detailed description of the experiments can be found in Garber
et al. [29], Gordon et al. [30], and Mandl et al. [4]. For the sake of
comparability, we consider the same time-window as Regoes et al.,
i.e. a window ranging from day 0 (start of infection) to day 30. In
one of the rhesus macaques (animal RFT8) no SIV infection could
be established. This animal was therefore excluded from further
analysis. In total, we consider 8 SMs (all infected with SIVsmm) and
8 RMs (4 infected with SIVmac239 and 4 infected with SIVsmm).
Figure 1 shows the measurements relevant for this study: the
virus-load, the density of proliferating CD4+ T-cells, the density of
proliferating CD8+ T-cells, and the density of NK cells. The
fraction of proliferating CD4+ and CD8+ T cells was assessed by
staining for the nuclear antigen Ki67, which is expressed by
cycling cells. We consider the density of proliferating CD4+ T-cells
as representative for the size of the target cell population and the
density of proliferating CD8+ T-cells as a surrogate measure for
the SIV-specific cellular immunity. We will therefore refer to the
density of proliferating CD4+ T-cells and of proliferating CD8+ T-
cells also as ‘‘target cells’’ and ‘‘cellular immunity’’, according to
the functional role we assume these populations to play. Data on
the density of NK cells were only available for all sooty mangabeys
and for 4 out of 8 rhesus macaques (RPB8, RSO8, RYE8, RZS8).
Models
The data were analyzed by using population dynamic models,
which describe the virus dynamics as a function of target cells,
CD8+ T-cells, and NK cells. The models are fitted to the virus
load. Hereby, the measurements of target cells, CD8+ T-cells, and
NK cells were used as explanatory variables. Importantly, the
model does not aim to explain the measurements of these cell
populations, but considers them only as factors that might explain
viral replication. A detailed account of this approach can be found
in [9].
In order to assess the role of target-cell limitation and cellular
immunity in early SIV infection, we compared the fits of two
nested models, which describe the virus dynamics by taking into
account either target cells only or target cells and specific cellular
immunity. These models are referred to as the target-cell model
and the CD8+ T cell model, respectively. Mathematically, these
models read
dv
dt
~v½rT(t){a  target{cell model ðÞ , and ð1Þ
dv
dt
~v½rT(t){kE(t){a  CD8z T cell model ðÞ , ð2Þ
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proliferating CD4+ T-cells and of proliferating CD8+ T-cells,
respectively. The parameters r, a, and k are chosen for each animal
such that T(t) and E(t) give the best possible prediction of v (see
below).
In order to test the impact of the non-adaptive immune system
on our results, we extended the above models by adding NK cell
number as an explaining factor. We incorporate the impact of
NK cells by using two different proxies: either the total density of
NK cells (characterized as CD32 CD202 CD16+ cells) or only
the density of activated NK cells (i.e. Ki67+ NK cells). The
second approach is identical to the one used of CD8+ and CD4+
T-cells. The first approach can be justified by the fact that, in
contrast to CD8+ T-cells, NK cells do not recognize specific
antigens. Thus, every NK cell can potentially inhibit virus
replication by either killing infected cells or by IFN-gamma
production [31], and their effect is most likely proportional to
their level. We would like to emphasize that we do not assume
that every NK cell is cytotoxic, or that every NK cell has anti-
viral activity. We only assume that the impact of NK cells is
proportional to their abundance (see discussion). The extensions
of the target-cell model and the CD8+ T cell model are referred
to as the NK-model and the CD8+ T cell & NK model.
Mathematically these models read
dv
dt
~vr T t ðÞ {a{nN t ðÞ ½  NK model ðÞ , and ð3Þ
dv
dt
~v½rT(t){kE(t){a{nN(t) 
CD8z T cell & NK model ðÞ ,
ð4Þ
where N(t) denotes the number of NK cells and the parameter n is
chosen according to the best fit criterion.
Fitting and statistics
We illustrate the fitting-procedure for the CD8+ T cell & NK
model: First the differential equation of the model (4) can be
integrated to
ln(v(t)){ln(v(t0))~
r
ð t
t0
T(t)dt{k
ð t
t0
E(t)dt{n
ð t
t0
N(t)dt{a(t{t0):
ð5Þ
If t0…tk , denote the time points for which measurements of v are
available then the parameters r, k, a and n are chosen such that the
residual sum of squares
SSQCTL{NK~
X n
i~0
ln(v(ti)){ln(v(t0)){r
ð ti
t0
T(t)dt
2
6 4
{k
ð ti
t0
E(t)dt{n
ð ti
t0
N(t)dt{a(ti{t0)
3
7 5
2 ð6Þ
is minimized. The integrals in the sum are computed from the
measurements of the cell numbers T ,E,a n dN by first
interpolating these measurements by a piecewise linear function,
resulting in the functions T(t), E(t),a n dN(t),a n dt h e n
integrating these interpolating functions. As expression (5) is
linear in the parameters r, k, a and n, the best fit can be found
using a standard linear-model solver such as the lm() routine of
the R language [32]. Biologically, the parameters r, k, a and n
must be larger than or equal to 0. If the best fit of (5) does not
fulfill these conditions, one or several of the parameters r, k, a
and n is set to 0 and the fitting procedure is repeated with these
reduced functions. From all the ‘‘reduced fits’’, that one is
chosen, which yields the minimal sum of squares while fulfilling
the biological conditions.
The fits for the target-cell, the CD8+ T cell, and the NK model
are obtained in a similar way as for the CTL-NK model. In
formula (5) the parameters that do not occur in the differential
equation of the model (i.e. equation 1, 2, or 3 for the target-cell,
CD8+ T cell, and NK model respectively) are set to 0 and the
remaining parameters are chosen such that the corresponding sum
of squares (SSQtarget-cell, SSQCD8+ T cell, and SSQNK) is minimized.
We can statistically compare two of the above models, for
instance model 1 and model 2, if they are nested, i.e. if model 1
results from model 2 by setting one of the parameters to 0. In such
cases, model 2 will always provide a better fit than model 1,
because model 1 is included as a special case in model 2. Whether
this improvement in the quality of fit is significant can then be
assessed by performing an F-test. The corresponding test statistic is
F1,2~
(SSQ1{SSQ2)=(df1{df2)
SSQ2=df2
:
Here SSQi denotes the residual sum of squares of the model i,
and dfi refers to the corresponding degrees of freedom. The p value
that corresponds to the value of F is then calculated from the
Fisher Distribution with degrees of freedom df1-df2 and df2, i.e
F(df1-df2,d f 2). This comparison between models can be made
either for each animal individually, or, as we mostly do in this
article, for all animals of a species taken together. In the latter case,
the residual sum of squares obtained by fitting the models to each
animal and their corresponding degrees of freedom have to be
summed to perform the F-test.
Figure 2 illustrates the statistical comparisons that are made
in this article. The most important of these comparisons is the
one between the target-cell model and the CD8+ Tc e l lm o d e l
(comparison i in Figure 2), which assesses the relative
importance of target cells and specific cellular immunity for
explaining the virus-load dynamics. If NK-cell counts are
available, one can ask in addition whether taking NK cells into
a c c o u n ti m p r o v e st h ef i to ft h et a r g et-cell model (comparison ii),
whether taking specific cellular immunity into account improves
the fit of the NK model (comparison iii), and whether taking NK
cells into account improves the fit of the CD8+ Tc e l lm o d e l
(comparison iv).
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